
MediXall Group (OTCQB: MDXL) CEO Interview Series
MediXall Group (OTCQB: MDXL) CEO: Michael Swartz SVP Marketing: Vincent Caputo THIS INTERVIEW HAS EXPIRED
MediXall Group (OTCQB: MDXL) CEO: Michael Swartz SVP Marketing: Vincent Caputo THIS INTERVIEW HAS EXPIRED
Noble Capital Markets’ Fifteenth Annual Investor Conference at the W Hotel, Fort Lauderdale, Florida on Monday, January 28th at 10:00am Eastern Standard Timein Studio 2. […]
Generex Biotechnology (OTC: GNBT) CEO: Joe Moscato THIS INTERVIEW HAS EXPIRED
Marker Therapeutics (NASDAQ: MRKR) CEO and President: Peter Hoang THIS INTERVIEW HAS EXPIRED
DURECT Corporation (NASDAQ:DRRX) President and CEO: Jim Brown THIS INTERVIEW HAS EXPIRED
Albireo Pharma, Inc. (Nasdaq: ALBO) CEO: Ron Cooper THIS INTERVIEW HAS EXPIRED
Eidos Therapeutics, Inc. (Nasdaq:EIDX) President and CMO: Jonathan Fox CBO: Cameron Turtle THIS INTERVIEW HAS EXPIRED
Tyme Technologies (NASDAQ: TYME) Chief Scientific Affairs Officer: Dr. Jonathan Eckard THIS INTERVIEW HAS EXPIRED, PLEASE CHECK OUT OUR FEATURED INTERVIEW SECTION FOR OTHER EXCITING STORIES.
Company’s Third Consecutive Quarter with Greater than 30% Year-Over-Year Revenue Growth […]
Vaccinex, Inc. (Nasdaq:VCNX) CEO: Maurice Zauderer THIS INTERVIEW HAS EXPIRED
Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com